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ABSTRACT
Objectives: To determine to what extent underlying
data published as part of Quality and Outcomes
Framework (QOF) can be used to estimate smoking
prevalence within practice populations and local
areas and to explore the usefulness of these
estimates.
Design: Cross-sectional, observational study of QOF
smoking data. Smoking prevalence in general
practice populations and among patients with chronic
conditions was estimated by simple manipulation of
QOF indicator data. Agreement between estimates
from the integrated household survey (IHS) and
aggregated QOF-based estimates was calculated. The
impact of including smoking estimates in negative
binomial regression models of counts of premature
coronary heart disease (CHD) deaths was assessed.
Setting: Primary care in the East Midlands.
Participants: All general practices in the area of
study were eligible for inclusion (230). 14 practices
were excluded due to incomplete QOF data for the
period of study (2006/2007–2012/2013). One
practice was excluded as it served a restricted
practice list.
Measurements: Estimates of smoking prevalence in
general practice populations and among patients with
chronic conditions.
Results: Median smoking prevalence in the practice
populations for 2012/2013 was 19.2% (range
5.8–43.0%). There was good agreement (mean
difference: 0.39%; 95% limits of agreement (−3.77,
4.55)) between IHS estimates for local authority
districts and aggregated QOF register estimates.
Smoking prevalence estimates in those with chronic
conditions were lower than for the general population
(mean difference −3.05%), but strongly correlated
(Rp=0.74, p<0.0001). An important positive
association between premature CHD mortality and
smoking prevalence was shown when smoking
prevalence was added to other population and service
characteristics.
Conclusions: Published QOF data allow useful
estimation of smoking prevalence within practice
populations and in those with chronic conditions; the
latter estimates may sometimes be useful in place of
the former. It may also provide useful estimates of
smoking prevalence in local areas by aggregating
practice based data.
BACKGROUND
Despite smoking prevalence in England
falling ‘below 20% for the ﬁrst time in 80
years’,1 reducing smoking remains a key
public health priority in England as in many
countries, with local authorities and primary
care services being expected to play a key
role in local tobacco control services.2 In
addition, clinical commissioning groups
(CCGs), membership organisations respon-
sible for planning, organising and purchas-
ing nationally funded healthcare within their
local areas, have their own health targets.
Reducing smoking prevalence is a key
component of many targets, for example,
improving chronic obstructive pulmonary
disease (COPD) outcomes3 and reducing
inequalities in coronary heart disease
(CHD).4 Reliable estimates of smoking preva-
lence for practice populations and local
Strengths and limitations of this study
▪ This paper clearly demonstrates that useful esti-
mations of smoking prevalence within practice
populations can be calculated from routine data
published through the Quality and Outcomes
Framework (QOF).
▪ Our analysis shows that estimates of smoking
prevalence in those with chronic conditions can
be used in some situations in place of an esti-
mate for the general population, if this is not
available.
▪ Comparisons with local area estimates suggest
QOF-based estimates are useful for estimating
smoking prevalence in both practice populations
and in local areas.
▪ QOF data rely on self-reported smoking status,
recorded in the previous 27 months, which may
underestimate smoking status or the effective-
ness of interventions.
▪ This study does not have access to individual
patient data limiting our understanding of
patients who do not have smoking status
recorded and the possible impact of missing
data on estimates of smoking prevalence.
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areas are useful to assess need, inform targeting of inter-
ventions delivered through primary care and to evaluate
those interventions. For practices and CCGs it is import-
ant to be able to evaluate different approaches to
smoking cessation and to understand the different levels
of risk in different practices. Practice based estimates are
of particular importance for research into a variety of
health outcomes and their associations with primary
care. Research of this type generally aims to take
characteristics of the practice populations into account
and the inclusion of smoking prevalence has been
shown to be important in the interpretation of other
factors, in particular socio-economic deprivation.5 6
Currently a variety of measures of smoking prevalence in
practice populations are being used6 7 and some studies
do not include a measure of smoking,8–10 despite the
recognised associations between smoking prevalence
and a range of chronic conditions.11
National surveys
In England, there are various national surveys of
smoking prevalence including the Health Survey for
England12; the General Lifestyle Survey13; the Smoking
Toolkit Study (STS) and the Integrated Household
Survey (IHS). The IHS began in 2009 and is a composite
survey including questions on smoking habits (involving
over 420 000 adults in 2011). IHS statistics are desig-
nated as experimental, in a ‘testing phase’ and not yet
fully developed,14 but estimates are available for local
authorities. It could, therefore, be argued that there is
no gold standard measure of smoking in local areas, and
there are no surveys which aim to establish the smoking
prevalence within practice populations.
Patient records
Analyses of individual patient records, using the THIN
(The Health Improvement Network)15 and
QRESEARCH16 databases, provide strong evidence that
smoking status within primary care medical records
could be used to monitor national smoking patterns.
There was good agreement between smoking prevalence
based on medical records in the THIN database and
those predicted by GHS: 22.4% compared to 21.8%
respectively in men; 18.9% compared to 20.2% respect-
ively in women.17 Estimates of smoking prevalence based
on the medical records in the QRESEARCH database
have also shown good agreement with national surveys,
in this case the Health Survey for England.18
Quality and Outcomes Framework
The national Quality and Outcomes Framework (QOF)
is a payment for performance system which was intro-
duced in England in 2004 to improve the quality of
primary care for patients. Practices are awarded points
for achieving targets and these points are translated into
ﬁnancial reward. Since its inception QOF has included
indicators relating to smoking.19 The underlying aim of
these indicators has not changed over the years; (a)
practices should record smoking status in patient notes
and (b) for those who smoke, smoking cessation advice/
support/treatment should have been offered. Until
2012/2013 the focus was on targeting smoking cessation
advice to those with chronic conditions. Table 1 sum-
marises QOF smoking indicators 2006/2007–2014/2015.
The QOF indicators have not been designed to deter-
mine smoking prevalence within the practice popula-
tion; indeed it is clearly stated that “QOF provides no
information on numbers of smokers and non-
smokers”,20 attributing this mainly to the condition-
speciﬁc nature of the indicator. The wording has not
changed since the inclusion of the two new indicators
which apply to the general population and are not
condition-speciﬁc.
Objective
In this paper we aim to explore to what extent under-
lying data published as part of QOF can be used to esti-
mate smoking prevalence within practice populations.
The usefulness of these estimates are explored by (i)
comparing aggregated data with local area estimates
from other sources and (ii) including practice level esti-
mates in a model of CHD mortality.
METHOD
Sample
All practices within three primary care trusts (PCTs), the
organisational unit for administering general practices
in England (2006/2007 to 2011/2012) in the East
Midlands, were eligible for inclusion in the study. 215
practices with QOF data available for the 7 ﬁnancial
years were included in the analysis. 14 practices were
excluded because they lacked data for all 7 years. One
practice was excluded from the study as it served a
restricted practice list; another practice was excluded
from the study as 2012/2013 QOF data strongly sug-
gested an error.
Manipulation of QOF data
QOF data can be downloaded from the Health and
Social Care Information Centre website containing infor-
mation for all practices in a region21; table 2 illustrates
the type of data available.
Two key QOF indicators are used in the calculations
of smoking prevalence in the total practice population:
▸ SM07 ‘The percentage of patients aged 15 years and
over whose notes record smoking status in the pre-
ceding 27 months’
▸ SM08 ‘The percentage of patients aged 15 years and
over who are recorded as current smokers who have a
record of an offer of support and treatment within
the preceding 27 months’
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Table 1 Summary of smoking indicators for which underlying achievement is published
General form of the indicator
Patient group
Patients with any, or any combination of the
following conditions: CHD, stroke or TIA,
hypertension, diabetes, COPD or asthma*
All patients aged
15 years+
Percentage of patients whose notes record
smoking status†
SM01: 2006/2007 and 2007/2008
SM03: 2008/2009–2011/2012
SM05: 2012/2013
SMOK002: 2013/2014–2014/2015
Records 22: 2006/
2007 and 2007/2008
Records 23: 2008/
2009–2011/2012
SM07: 2012/2013
SMOK001: 2013/
2014—retired in 2014/
2015
Percentage of patients who are recorded as
current smokers whose notes contain a record
that smoking cessation advice or referral to a
specialist service, where available, has been
offered within the previous 15 months‡
SM02: 2006/2007 and 2007/2008
SM04: 2008/2009–2011/2012
SM06: 2012/2013
SMOK005: 2013/2014–2014/2015
SM08: 2012/2013
SMOK004: 2013/
2014–2014/2015
The practice supports smokers in stopping
smoking by a strategy which includes providing
literature and offering appropriate therapy.
Information 5: 2006/
2007–2011/2012
SMOK003: 2012/
2013–2014/2015
*In 2008/2009 chronic kidney disease, asthma, schizophrenia, bipolar affective disorder or other psychoses were added to the list of chronic
conditions and in 2012/2013 peripheral arterial disease was added.
†For those with chronic conditions, the record must have been made in the past 15 months, reduced to 12 months in 2013/2014, for all
patients the period is 27 months, reduced to 24 months in 2013/2014.
‡In 2012/2013 this changed to ‘who have a record of an offer of support and treatment within the preceding 15 months’, the period is
27 months for all patients, reduced to 12 months and 24 months respectively in 2013/2014.
COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack.
Table 2 Example of QOF data from 2012/2013, showing how it can be used to calculate smoking prevalence for individual
practices
Example practices
QOF description
Interpretation for purposes of
calculating smoking prevalence A B C D E
SM07 points 11 10.5 10.8 9.6 11
SM07 numerator Patients* whose notes contain a
record of smoking status
3450 1319 6276 31 948 6504
SM07 denominator Patients who are eligible to be
included in this indicator†
3721 1497 7033 37 654 7212
SM07 UA 92.70% 88.10% 89.20% 84.80% 90.20%
SM08 points 12 9.9 12 8.9 12
SM08 numerator Patients who are recorded as
current smokers and have a record
of an offer of support, etc
1024 325 1578 8439 2165
SM08 denominator Patients who are recorded as
current smokers
1129 401 1586 10 931 2373
SM08 UA 90.70% 81.00% 99.50% 77.20% 91.20%
Calculation to determine percentage
who are smokers SM08 den/SM07
den
1129/3721 401/1497 1586/7033 10 931/37 654 2373/7212
Estimate of smoking prevalence 30.30% 26.80% 22.60% 29.00% 32.90%
*Patients aged over 15.
†For example, patients who are newly registered with the practices (less than 3 months) are excluded from the indicator.
QOF, Quality and Outcomes Framework.
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These can be summarised as follows:
SMOKING STATUS INDICATOR ðSM07Þ ¼
No: of patients who have their smoking status recorded
No: of eligible patients in the practice
SMOKING CESSATION INDICATOR ðSM08Þ ¼
No: of patients who have a record of cessation support
No: of patients recorded as current smokers
The denominator of the SMOKING STATUS
INDICATOR (SM07) provides an estimate of the sample
of the practice population whose smoking status should
be recorded. This includes the whole practice popula-
tion aged over 15, with the exception of people who
have joined the practice in the 3 months prior to the
data extraction point and patients who refuse to provide
their smoking status.
The denominator of the SMOKING CESSATION
INDICATOR (SM08) provides an estimate of those who
are recorded as current smokers.
In addition, indicators of a similar nature were
included but applying to those with any, or any combin-
ation, of a range of QOF speciﬁed chronic conditions
(SM05 and SM06).
Using the data given for these indicators, it is possible
to estimate the smoking prevalence in a practice popula-
tion, as summarised below.
SMOKING PREVALENCE ESTIMATE
¼ No: of patients recorded as current smokers
No: of eligible patients in the practice
¼ Denominator of SM08
Denominator of SM07
For example, for practice A the denominator for SM07
is 3721—the number of eligible patients in the practice.
The denominator for SM08 is 1129, indicating that
there are 1129 registered patients recorded as current
smokers. Hence smoking prevalence can be estimated as
1129/3721 or 30.3%. Table 2 gives worked examples for
ﬁve practices. This method was used to estimate
smoking prevalence for the total practice population in
2012/13 and, using appropriate indicators, for those
with chronic conditions from 2006/2007 to 2012/13
(SM05 and SM06 in 2012/13).
In addition, the percentage of the practice population
with a chronic condition was determined using the
denominator of SM07 as a measure of the practice
population and the denominator of SM05 as a measure
of the practice population with a chronic condition.
Comparisons with local area estimates
Practice postcodes were linked to local authority districts
using the National Statistics Postcode Directory (NSPD)22
and then conﬁrmed by visual check of addresses. Practice
level data were aggregated to estimate smoking preva-
lence in local authority districts. Details of the estimated
population of each district, the aggregated population
for which smoking status has been determined, the
number of practices in each district and the sample size
for the IHS 2011/2012 are included in table 3. These esti-
mates were compared to estimates of smoking prevalence
in local authority districts based on data from the IHS.24
Modelling
To determine the importance of being able to estimate
smoking prevalence in practice populations, the estimate
of smoking prevalence was included in a model to deter-
mine the associations of premature CHD (under 75)
mortality with various population and service character-
istics; the methods are described by Honeyford et al.10
Here, counts of premature CHD deaths (between April
2006 and March 2009) were modelled using negative
binomial regression, using the same explanatory vari-
ables but including estimated smoking prevalence for
those with chronic conditions based on QOF 2006/
2007. Service and population characteristics derived
from QOF registers from 2006/2007 were originally
selected for inclusion in the study but an estimate of
smoking prevalence for the general population was not
available for this year.
RESULTS
Estimates using QOF data
Estimation of overall smoking prevalence using QOF
smoking indicators 2012/2013
The median underlying achievement for the recording of
smoking status in the total practice population was 88.1%
in 2012/2013 (IQR: (83.7, 91.0)). The median estimate of
smoking prevalence in practice populations was 19.2%,
ranging from 5.8% to 43.0% (IQR: (15.1%, 22.9%)).
Estimates of smoking prevalence in those with chronic
conditions using QOF smoking indicators 2012/2013
The underlying achievement for recording smoking
status in those with chronic conditions was higher than
for the total practices population (96.6% IQR (95.0,
97.7)). The median practice based estimate for those
with any or any combination of a speciﬁc list of chronic
conditions was 15.4% (IQR: 12.6% to 19.4%), ranging
from 7.1% to 51.5%.
The estimates of smoking prevalence in those with
chronic conditions have been consistent since 2006/2007,
with the median varying slightly during that time.
Concordance was high between estimates for all years;
Lin’s concordance coefﬁcient25 was greater than 0.92 and
mean difference was less than1 in all cases (see online sup-
plementary table S1 in appendix for more details).
Comparisons with local area estimates
Estimates of smoking prevalence were in line with esti-
mates derived from the IHS. Aggregating over the total
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area, smoking prevalence was 19.5%, compared to
19.3% when IHS district level data were aggregated over
the same area. When practice data were combined to
give estimates of smoking for local authority districts
there was a strong positive correlation (Rp=0.86,
p<0.0001) and good agreement (mean difference:
0.39%; 95% limits of agreement (−3.77, 4.55)) between
estimates based on QOF registers and IHS estimates
(ﬁgure 1).26
When the estimates of prevalence for those with
chronic conditions were aggregated into local authority
districts, estimates were lower than IHS estimates for the
majority of areas.
Associations between measures
Association between smoking prevalence in the general
practice population and those with chronic conditions
Smoking prevalence in those with chronic conditions
was lower than in the general practice population. The
mean difference between the two estimates was −3.05%
(95% limits of agreement: (−8.65, 1.56)).The
Bland-Altman plot does not suggest a strong pattern,
despite some evidence that the difference increases as
the average increases (ﬁgure 2). There was a strong posi-
tive correlation (Rp=0.92, p<0.0001) between the overall
estimate of smoking prevalence within a practice popula-
tion and in those with chronic conditions. A regression
model was developed to predict smoking prevalence in
the general population based on the prevalence in those
with chronic conditions; removal of outliers improved
model ﬁt.
Associations between recording of smoking status and
prevalence
There was a strong positive correlation between record-
ing of smoking status in the general population and in
those with chronic conditions (underlying achievement
for SM07 and SM05 respectively) (Rp=0.74, p<0.0001).
There was no evidence of an association between
smoking prevalence in the general population and
recording of smoking status (Rp=−0.07, p=0.28) or the
percentage with a chronic condition (Rp=0.03, p=0.67).
Including smoking prevalence estimates in models of
mortality
Table 4 shows incident rate ratios (IRRs), 95% CIs and
associated p values for the original and modiﬁed
models. Inclusion of the smoking prevalence variable in
the model reduced the strength of the associations
between deprivation and premature mortality, and per-
centage white and premature mortality. Sensitivity ana-
lysis considering the impact of exception reporting
indicates no impact on interpretation (see Doran et al 27
for details of exception reporting).
Table 3 Comparison of the population of each district based on the 2011 Census and aggregation QOF based practice data
Local authority
Population aged
15 and over (2011
Census)*
Population included
in QOF indicator
SM07†
Number of
general
practices‡
IHS sample
size 2011/
2012§
Leicestershire
Blaby 77 600 67 895 9 301
Charnwood 139 800 152 533 24 396
Harborough 70 200 69 168 8 234
Hinckley and Bosworth 87 800 84 159 12 305
Melton 41 900 34 912 2 130
North West Leicestershire 77 000 78 331 14 242
Oadby and Wigston 47 100 48 054 9 167
Northamptonshire
Corby 49 400 57 112 5 131
Daventry 64 100 71 902 8 223
East Northamptonshire 70 900 55 279 8 217
Kettering 75 900 87 059 9 180
Northampton 171 600 184 370 27 446
South Northamptonshire 69 700 60 391 8 205
Wellingborough 61 300 61 013 9 172
Unitary Authorities
Leicester 264 600 293 156 59 1475
Rutland 31 300 29 628 4 416
Totals 1 400 200 1 434 962 215 5240
*Data based on 2011 Census available from ONS.23
†Based on QOF registers accessed from ref. 21
‡Practices are matched to local authority districts based on the postcode of the practice.22
§Based on IHS data 2011/2012.24
QOF, Quality and Outcomes Framework; IHS, integrated household survey.
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DISCUSSION
Principal findings
These results show how the QOF registers required
as part of the general practice pay for performance
scheme in England can be used to estimate smoking
prevalence in practice populations and that these
estimates are useful when analysing patterns of
mortality. Practice based estimates can be aggregated
to provide estimates of smoking prevalence in local
areas.
When smoking prevalence is estimated in the general
population using QOF indicators there is good agree-
ment with estimates of IHS smoking prevalence for
similar geographical areas.
Figure 1 Relationship between aggregated QOF estimates and IHS estimates for local authority districts. (A) Association
between estimates (dashed line: estimates are equal). (B) Bland-Altman plot showing relationship between difference in
estimates and mean difference (solid line: mean difference; dashed lines: 95% limits of agreement). QOF estimates based on
2012/2013 data; IHS estimates based on 2011/2012 survey. QOF, QOF, Quality and Outcomes Framework; IHS, integrated
household survey
Figure 2 Relationship between QOF estimates for the general population and those with chronic conditions (2012/2013),
(A) Association between estimates (dashed line: estimates are equal; solid line: fitted line). (B) Bland-Altman plot showing
relationship between difference in estimates and mean difference (solid line: mean difference; dashed lines: 95% limits of
agreement). SM07 and SM08 (2012/2013) used for QOF estimates for the general population; SM05 and SM06 (2012/2013)
used for QOF estimates for those with chronic conditions. QOF, QOF, Quality and Outcomes Framework
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QOF data can also be used to estimate smoking preva-
lence in those with chronic conditions, which is gener-
ally lower than smoking prevalence in the general
population. There is good agreement between the esti-
mates in successive years. The correlation between esti-
mates of smoking prevalence in the general population
in 2012/2013 and those with chronic conditions is
strong. These strong correlations suggest that the esti-
mates based on previous years can be used in place of
smoking prevalence in the general population for some
purposes. Regression analysis suggests that smoking
prevalence in those with chronic conditions can be used
to predict smoking prevalence in the general practice
population, for practices with a typical patient list.
When an estimate of smoking prevalence in those
with chronic conditions was used in a study of the associ-
ation between premature CHD mortality and various
population and service characteristics an important posi-
tive association between CHD mortality and smoking
prevalence was shown.
Strengths and weaknesses
The agreement between IHS based area estimates of
smoking prevalence and estimates based on combining
QOF data provides evidence to suggest that manipulat-
ing QOF data results is a useful measure of smoking
prevalence within practice populations when compared
to other available measures. This is supported by the
work of Szatkowski et al17 which found good agreement
between national smoking prevalence predicted by
patient records and the General Household Survey. In
addition, practice based QOF data can be aggregated to
provide local area estimates of smoking prevalence
based on a much larger sample size than other surveys.
When comparing practices and analysing patterns
across practices, it is important that the estimate is con-
sistent across practices. The percentage of patients who
do not have their smoking status recorded varies from
40% to less than 1%, but the characteristics of these
patients are not known. Recording of smoking status has
been shown to vary between groups18 19 28; women,
older people and those with chronic conditions were
more likely to have their smoking status recorded.
National surveys suggest that smoking rates are lower in
these groups and therefore smoking prevalence from
QOF may underestimate actual smoking prevalence.
The implications of this will vary between practices,
dependent on the proportion of these groups within
their practice populations. Our analysis did not ﬁnd an
association between the percentage with a chronic con-
dition and the recording of smoking status in the total
population or the estimate of smoking prevalence.
QOF data are based on self-reported smoking status,
which has been shown to be reliable in the general
population,28 but to underestimate smoking prevalence
in pregnant women.29 In addition, practices are only
asked to record smoking status in the preceding
27 months, meaning the estimates may be useful in
assessing need and analysing associations, but will have
disadvantages in assessing the effectiveness of interven-
tions, unless practices commit to more regular
recording.
Practice level smoking data have been aggregated to
local authority districts based on practice postcode
rather than patient postcodes. General practice
Table 4 Estimated incident rate ratios (IRRs) for premature (U75) CHD mortality count (n=215)*
Without smoking prevalence
variable
With smoking prevalence
variable
Explanatory variable IRR 95% CI p Value IRR 95% CI p Value
Percentage white patients 1.007 (1.003 to 1.012) 0.002 1.001 (0.995 to 1.007) 0.657
Deprivation score (IMD 2007) 1.017 (1.011 to 1.024) <0.0001 1.005 (0.995 to 1.015) 0.348
Prevalence of diabetes (QOF 2006/2007) 1.108 (1.020 to 1.203) 0.015 1.095 (1.008 to 1.187) 0.031
Percentage over 65 1.060 (1.038 to 1.083) <0.0001 1.067 (1.044 to 1.091) <0.0001
Percentage male patients 1.073 (1.035 to 1.111) <0.0001 1.058 (1.021 to 1.097) 0.002
Number of GPs per 1000 patients 1.209 (0.894 to 1.637) 0.218 1.113 (0.821 to 1.508) 0.491
Hypertension detection 2006/2007
(QOF 2006/2007)
0.984 (0.955 to 1.014) 0.300 0.988 (0.959 to 1.018) 0.416
Percentage of patients offered smoking cessation
advice (SM02—QOF 2006/2007)
1.006 (0.996 to 1.016) 0.271 1.010 (1.000 to 1.021) 0.057
Percentage of serum cholesterol (CHD08—QOF
2006/2007)
0.989 (0.980 to 0.999) 0.028 0.992 (0.983 to 1.002) 0.109
Percentage of aspirin (CHD09—QOF 2006/2007) 1.007 (0.986 to 1.029) 0.514 1.003 (0.982 to 1.025) 0.777
Percentage of patients with recalled perception of
being able to see preferred GP (QOF 2006/2007)
0.995 (0.990 to 1.000) 0.069 0.995 (0.990 to 1.000) 0.061
Percentage of smoking prevalence—estimated
(QOF 2006/2007)
1.031 (1.012 to 1.052) 0.002
*IRR, 95% CIs and associated p values as a result of negative binomial model of count of premature mortality caused by CHD.
CHD, coronary heart disease; GP, general practitioner; QOF, Quality and Outcomes Framework.
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catchments are not constrained by local authority
boundaries; however, studies have shown that 80% of
patients live within a 10 min car journey of their prac-
tice,30 suggesting that patients choose practices close to
where they live. It is relatively common for practice post-
codes to be used as a proxy for patient postcodes;
however, when used to estimate deprivation this has
been found to underestimate relationships between
deprivation and health outcomes.31 32
Further work using individual patient records is neces-
sary to analyse the frequency of recording of smoking
status and the characteristics of patients for whom no
smoking status is recorded or have been excluded on
the basis of exception reporting. In this analysis practice
level data have been aggregated to estimate smoking
prevalence in local authority districts. Analysis of patient
level postcode information, not available for this study,
would allow estimates of smoking prevalence for smaller
geographical areas to be made. These could then be
compared to modelled estimates or locally commis-
sioned surveys, where they exist.
Implications
Manipulating QOF data is an easy and cost-effective
method of estimating smoking prevalence in both prac-
tice populations and local areas, although further work
is necessary to determine the validity of using aggre-
gated practice level data for local area estimation. Both
local area and practice based estimates are important to
those tasked with reducing smoking rates and improving
the nation’s health. CCGs and public health depart-
ments in local authorities need them to target smoking
cessation and other additional resources. Understanding
more about the patient populations would enable
similar practices to be compared when considering dif-
ferences in health outcomes and the apparent effective-
ness of interventions.33
Current estimates of smoking prevalence in local areas
are based on the Integrated Household Study. The IHS
is currently in an experimental phase since the weight-
ing methodology needs to be assessed and potentially
revised.34 Aggregated practice level data include the
majority of the resident adult population in local areas
and could therefore be a more useful measure of local
area smoking prevalence, at district level and at smaller
local areas than are currently available through the IHS.
Analysis of patient level geographical data is necessary to
determine the potential utility of simple and more
complex aggregation methods.
When estimates of smoking prevalence are included
in the analysis of the associations between premature
CHD mortality and practice population and service
characteristics, there are reductions in the magnitude of
the IRRs for both deprivation and percentage white.
This suggests that these may be acting as surrogate
markers of other lifestyle factors, such as smoking preva-
lence. Hence, the lack of reliable smoking information
may be leading to relative over emphasis being placed
on socio-economic deprivation, often described using an
index of multiple factors. Reliable measures of smoking
prevalence will improve our understanding of the rela-
tive importance of deprivation and other characteristics
in explaining inequalities in a variety of health
outcomes.
Smoking prevalence in those with chronic conditions
is typically lower than in the general population. This
may be due to diagnosis increasing motivation to quit
smoking,35 the increase in smoking cessation advice and
support36 or the age and gender proﬁle of those with
chronic conditions. Smoking prevalence in those with
chronic conditions has not reduced over the 7 year
period covered in this analysis, possibly suggesting that
smoking cessation advice has limited effect, but this may
be due to the turnover of patients with chronic condi-
tions as a result of both premature mortality and new
diagnoses. A wide range of smoking cessation advice and
support has recently been reviewed by Zwar et al37; con-
sideration of how these impact on those with chronic
conditions is recommended as a result of this ﬁnding.
QOF smoking indicators have changed since 2004 and
continue to change. The introduction, in 2012/2013, of
an indicator which allows estimates of the smoking
prevalence within the general population is useful for
researchers as well as CCGs and public health ofﬁcials.
The removal of the indicator that covers the recording
of smoking status in the total population from QOF in
2014/2015 will impact on the methodology described in
this paper, although the number of patients who are
recorded as current smokers will continue to be avail-
able. The population of the practice will need to be
used as the denominator in the calculation of smoking
prevalence. It will be important to determine if the
smoking status declines after the removal of the indica-
tor; a recent study suggests that removal of indicators
does not lead to a decline in clinical activities.38
CONCLUSION
Data published through QOF allow useful estimations of
smoking prevalence within practice populations and in
those with chronic conditions to be made. These esti-
mates are important in developing our understanding of
differences in health outcomes between practices, and
are useful to both individual practices and CCGs when
comparing practice level health outcomes, to assess
need and to inform targeting. Aggregating practice level
data may also be useful to allow estimates of smoking
prevalence in local areas to be made. Revisions to QOF
means that researchers will need to update methodology
as indicators change.
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